Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy and Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip

NCT01461369 is registered in ClinicalTrials.gov with Iroko Pharmaceuticals, LLC as lead sponsor.

NCT NCT01461369
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01461369 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Fixed-Dose, Parallel-Group, Efficacy and Safety Study of Diclofenac [Test] Capsules in Subjects With Osteoarthritis of the Knee or Hip
Lead sponsor
Iroko Pharmaceuticals, LLC
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2011
Completion date
October 31, 2012
Enrollment
305 (actual)
Sites
40

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis